Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

Hutchinson-Gilford Progeria Syndrome causes rapid aging due to a gene mutation, with no cure yet, but research may lead to better treatments.

Early treatment with corticosteroids improved her eye condition significantly.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

A vitamin D receptor mutation causes rickets and affects immune responses.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Two girls experienced temporary hair loss after getting the HPV vaccine, which may be related to the vaccine.

HHV-6 reactivation may be linked to psychiatric disorders and can improve with antiviral treatment.

Vogt–Koyanagi–Harada disease can cause rare hair growth on normally hairless thumb skin.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

RNA-based treatments show promise for managing Hutchinson-Gilford Progeria Syndrome.

A black-skinned woman was diagnosed with Vogt-Koyanagi-Harada disease and treated with steroids and eye drops.

Growth hormone may protect skin from radiation damage.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Providing housing and case management reduces hospital visits for chronically ill homeless adults.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

VKHD can include rare oral symptoms like discolored teeth.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.